Forte Biosciences, Inc.

NASDAQ:FBRX

14.62 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q12017 Q12001 Q1
Operating Activities:
Net Income -8.392-12.511-7.42-5.872-9.955-8.896-6.753-4.877-3.4-3.035-2.567-3.341-7.751-5.812-4.804-4.576-5.1-34.761-2.05-1.564-0.69-0.63-1.185-24.435-12.88-9.073-2.567
Depreciation & Amortization 0.010.010.0090.0060.00300000000.0090.0130.0140.0140.0130.0140.0130.01100.2170.2160.510.0490.0660
Deferred Income Tax 000-4.658-0.00300000000003.831000-8.05800-2-1.2560.1791.0770
Stock Based Compensation 0.7910.8020.8050.780.7720.8550.8770.860.9061.1941.0551.2381.4731.0080.4950.5550.3750.0240.0020.0310.0020.0010.0023.7651.5210.5291.055
Change In Working Capital -5.7135.768-0.055-3.8910.242.5870.6721.1240.5540.464-0.463-1.4791.0810.8530.2650.204-3.027-0.178-0.830.1250.1350.0580.0651.626-0.179-1.077-0.37
Accounts Receivables 000000000000000000000000000
Change In Inventory 000000000000000000000000000
Change In Accounts Payables -0.1163.590.261-3.8662.2841.6640.1890.0180.4660.093-0.37-1.3841.345-0.221-0.0340.025-1.3531.859-0.9-0.9250.1080.285-0.492.886-0.179-1.077-0.37
Other Working Capital -5.5972.178-0.316-0.025-2.0440.923-0.1891.1060.0880.371-0.093-0.095-0.2641.0740.2990.179-1.674-2.0370.070.1250.0270.0580.065-1.6260.1791.0770.37
Other Non Cash Items 5.171-0.0050.5564.666-0.115-0.0210.6880.8420.441.1011.4252.6220.0611.2550.557-3.831-1.35330.885-0.90.7440.108-0.6190.7437.571-1.3980.911-0.093
Operating Cash Flow -8.133-5.936-6.667-8.969-9.058-5.475-5.204-2.893-1.94-1.377-1.975-3.582-5.127-3.938-4.03-3.803-7.739-4.016-2.865-0.653-0.553-1.19-0.375-12.219-12.708-7.567-1.975
Investing Activities:
Investments In Property Plant And Equipment 00-0.006-0.017-0.0710000000.0610000000-0.089-0.073-0.124-0.133-1.695-0.22-0.0530
Acquisitions Net 0000000000000000-0.0013.5830-42.13900-6.230000
Purchases Of Investments 00000-9.9650000000000000-51.16300-21.606-48.469-12.528-9.7490
Sales Maturities Of Investments 0000.00110.099000000000000012.72293.4730027.83645.8849.08713.5530
Other Investing Activites 00000.01-0.0100000-0.0610003.583-0.0010017.272-0.073-0.2826.23-0.0200.020
Investing Cash Flow 00-0.006-0.01610.028-9.965000000.0610003.583-0.0013.58312.722-0.089-0.073-0.4066.097-4.3-3.6613.7710
Financing Activities:
Debt Repayment 000000000000000000000008.631-1.85.5380
Common Stock Issued 0.00600.008-0.06324.825-0.0240.006-0.0557.28400.0120.0620.0190.0150.02742.683000.010.001000.24828.5180.0290.0410
Common Stock Repurchased 0.026-0.01-0.016-0-0-00-0.0550000000000000000000
Dividends Paid 000000000000000000000000000
Other Financing Activities -0.002-0.01-0.008-0.0124.77700.00607.44-0.11-0.034-0.039-0.003-0.0290.027-0.290.16624.0630.045-15.45906.4674.8562.9540-0.338-0.034
Financing Cash Flow -0.002-0.01-0.008-0.07524.777-0.0240.006-0.0557.44-0.11-0.034-0.039-0.003-0.0290.02742.3930.16624.0630.045-23.145004.85640.103-1.7715.241-0.034
Other Information:
Effect Of Forex Changes On Cash 000-0.1230000000-0.061000-3.58300-12.722-000-40.8130000
Net Change In Cash -8.135-5.946-1.326-9.18325.747-15.464-5.198-2.9485.5-1.487-2.009-3.621-5.13-3.967-4.00338.59-7.57423.63-2.82-0.742-0.626-1.19-31.31623.02-18.141.445-2.009
Cash At End Of Period 16.36324.49810.63511.96146.18520.43835.90241.144.04838.54840.03542.04445.66550.79554.76258.76520.17527.7494.1196.9397.6818.3079.49740.81317.7936.95540.035